City
Epaper

US Vice-President tests positive for Covid-19

By IANS | Updated: April 27, 2022 00:40 IST

Washington, April 27 US Vice President Kamala Harris tested positive for Covid-19 on undergoing rapid and PCR tests, ...

Open in App

Washington, April 27 US Vice President Kamala Harris tested positive for Covid-19 on undergoing rapid and PCR tests, her spokesperson said.

"She has exhibited no symptoms, will isolate and continue to work from the Vice President's residence," the spokesperson added on Tuesday in a statement.

Harris, 57, has not been a close contact to US President Joe Biden or the first lady "due to their respective recent travel schedules," the statement added.

The Vice-President will follow Centers for Disease Control and Prevention guidelines and the advice of her physic and will return to the White House when she tests negative, it said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Joe BidenWhite HouseKamala HarrisCenters for disease control and preventionUs centers for disease control and preventionU.s. centers for disease control and preventionDisease control and researchJoe bidensDisease control and prevention
Open in App

Related Stories

InternationalWhite House Again Shares Cryptic Pixelated Images on Social Media After Shaky Footage, Ringtone Video

Social ViralWhite House X Account Hacked? Two Strange Videos Posted by US President's Palace on Social Media Platform Confuse Netizens

InternationalVan Crashes Into Barricade Near White House, Driver Detained; Area Shut Down

International'Warrior Dividend': Donald Trump Announces $1,776 Christmas Bonus to Active US Soldiers

InternationalDonald Trump Slams Bondi Beach Anti-Semitic Terrorist Attack at Hanukkah Reception in White House

Health Realted Stories

HealthGujarat: Hotels, eateries fined for paneer display violations; 615 kg of substandard food destroyed

HealthMinistry of Social Justice clocks highest-ever Rs 11,810 crore expenditure in FY26

HealthIndia to boost biosimilar insulin, CGM manufacturing as Global South looks for support

HealthIndia clocks unprecedented foodgrain output, boosts institutional support to farmers

HealthIndia tightens watch on GLP-1 drugs amid safety and misuse concerns